CorMedix Inc

Healthcare · Biotechnology

7.30$ +0.0% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Balance Sheet

CorMedix Inc (CRMD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 904 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CRMD
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	29	22	15	21	14	13	9.6	5.9	8.0	19	27	28	34	29	27	24	40	49	84	81	75	69	65	68	62	62	59	57	91	82	68	58	78	119	150	253	751	826	816	904
Current Assets	29	22	15	21	14	13	9.4	5.7	7.9	19	27	27	34	29	27	24	39	48	83	80	73	66	63	65	60	60	57	55	89	79	63	53	73	115	145	248	260	367	383	481
Cash	9.8	8.1	6.8	7.9	5.2	10	8.2	4.7	6.4	18	18	15	20	17	12	16	34	42	76	73	66	53	45	49	43	43	25	20	53	44	35	29	35	41	66	159	48	146	178	257
Cash & Short-Term Investments	27	20	14	19	12	12	8.2	4.7	6.4	18	26	27	32	29	23	22	37	46	81	78	72	65	62	65	59	59	56	52	87	76	59	46	46	52	78	191	56	150	178	257
Receivables	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.3	0.0	0.0	-0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	0.0	0.0	0.2	17	52	55	43	160	171	155	161
Inventory	0.1	0.2	0.1	0.3	0.3	0.6	0.6	0.7	0.3	0.4	0.4	0.4	0.4	0.3	0.3	0.3	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	2.1	2.3	4.0	6.6	7.6	7.5	9.6	29	30	31	39
Property, Plant & Equipment	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	1.1	0.1	1.1	1.4	1.5	1.5	1.4	2.3	2.4	1.6	1.6	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.0	–	–	18	30	30	30
Intangible Assets	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	2.0	1.9	1.9	1.8	1.8	1.7	390	379	369	358
Total Liabilities	5.1	4.1	3.9	5.8	4.3	6.3	8.8	12	18	14	11	11	5.0	5.8	5.8	5.7	5.6	5.1	3.9	4.0	6.0	6.1	5.1	6.0	5.8	7.0	5.3	8.0	8.2	12	10	12	19	34	35	32	377	421	379	443
Current Liabilities	5.0	4.1	3.9	5.8	4.3	6.3	8.8	12	18	7.8	4.3	4.3	5.0	5.8	5.8	5.7	4.6	4.2	3.0	3.1	5.2	5.3	4.3	5.3	5.1	6.3	4.7	7.4	7.7	11	9.5	11	18	34	34	32	134	174	129	187
Short-Term Debt	0.0	0.0	0.0	2.0	–	–	–	–	–	–	0.0	–	–	0.0	–	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	1.4	1.4	–	–
Accounts Payable	1.8	1.6	1.7	1.8	1.4	1.8	3.7	7.3	7.9	2.6	1.5	0.9	1.1	1.0	1.3	1.4	2.0	1.1	1.5	0.9	1.1	2.2	1.7	2.5	1.8	2.2	1.4	2.9	2.4	4.3	2.8	3.3	1.3	1.7	1.9	5.8	20	7.9	13	10
Long-Term Debt	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	6.4	6.7	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	145	145	145	145
Shareholders' Equity	24	18	11	15	9.7	-152	0.8	-6.5	-9.5	-179	17	-185	29	-195	22	19	34	44	80	77	69	63	60	62	56	55	54	49	83	70	58	46	59	85	115	221	374	405	437	461
Retained Earnings	-113	-119	-127	-132	-142	-152	-162	-171	-181	-179	-184	-185	-190	-195	-201	-205	-211	-217	-225	-229	-238	-246	-253	-260	-267	-275	-286	-297	-307	-322	-336	-350	-353	-340	-319	-299	-191	-177	-138	-112
Shares Outstanding	7.8	8.1	8.1	11	12	13	15	16	19	21	23	24	24	26	26	26	30	32	36	38	38	38	38	40	41	42	44	45	57	57	58	58	59	62	69	72	86	94	93	92

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings